Peak6 Investments LLC Halozyme Therapeutics, Inc. Call Options Transaction History

Peak6 Investments LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	SELL	$30.28 - $38.74 $157,456 - $201,448	-5,200 Reduced 28.57%	13,000 $468,000
Q1 2023 May 12, 2023	SELL	$32.86 - $55.7 $161,014 - $272,930	-4,900 Reduced 21.21%	18,200 $695,000
Q4 2022 Feb 10, 2023	BUY	$40.06 - $59.44 $925,386 - $1.37 Million	23,100 New	23,100 $1.31 Million
Q4 2020 Feb 12, 2021	SELL	$25.81 - $43.62 $273,586 - $462,372	-10,600 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$25.74 - $29.63 $1.02 Million - $1.17 Million	-39,500 Reduced 78.84%	10,600 $278,000
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $814,125 - $1.34 Million	50,100 New	50,100 $1.34 Million

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.